Biohaven Ltd. (NYSE: BHVN) ("Biohaven"), a global clinical-stage biopharmaceutical company focused on the discovery, development, and commercialization ...

Sanofi's Wayrilz approved in the EU as the first BTK inhibitor to treat immune thrombocytopenia Novel treatment targets BTK through multi-immune modulation to help address the underlying causes of ITP ...

Xenon Pharmaceuticals (XENE) is undervalued given azetukalner's late-stage potential to transform epilepsy and mood disorder ...

Mondego Bio, a clinical-stage biotechnology company developing next-generation small-molecule immuno-oncology therapies, today announced the formal selection of its lead clinical candidate, ZE00-0388, ...

We lift the bonnet on a foundational piece of synth genius, and demonstrate how you can achieve its distinctive sound ...

Formation Bio has acquired the global rights, excluding in Greater China, to LNK01006 from Lynk Pharmaceuticals.

In this article, we examine ongoing challenges shaping target-based drug discovery and highlight how new technologies and ...

Alternanthera littoralis, commonly called Joseph’s Coat, is native to Brazil’s coastal regions and has a long history of use ...

Direct-fed Microbials (DFM) Market Surges to USD 6.2 Billion by 2033, Propelled by 7.0% CAGR - Verified Market Reports (R) ...

D network architecture and the backbone of 6G NTNs. Opportunities and challenges with NTNs. Non-terrestrial networks (NTNs) ...

The data center network has reached a critical point. As companies race to build massive XPU clusters for AI, traditional ...

A new study published in the journal Neurobiology of Sleep and Circadian Rhythms provides evidence that exposure to blue light can directly alter the baseline responsiveness of the human brain. The ...